© Reuters. FILE PHOTO: A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. REUTERS/Hannah McKay/File Photo GLOBAL BUSINESS WEEK AHEAD
(Reuters) – British drugmaker GSK on Wednesday beat analyst expectations for its first-quarter profit and sales, ahead of the planned listing of its large consumer healthcare division in July, and stood by its forecasts for 2022.
Be the first to comment